| The changing epidemiology of thyroid cancer: why is incidence increasing? R Vigneri, P Malandrino, P Vigneri Current opinion in oncology 27 (1), 1-7, 2015 | 411 | 2015 |
| Papillary thyroid cancer incidence in the volcanic area of Sicily G Pellegriti, F De Vathaire, C Scollo, M Attard, C Giordano, S Arena, ... JNCI: Journal of the National Cancer Institute 101 (22), 1575-1583, 2009 | 192 | 2009 |
| Heavy metals in the volcanic environment and thyroid cancer R Vigneri, P Malandrino, F Gianì, M Russo, P Vigneri Molecular and cellular endocrinology 457, 73-80, 2017 | 153 | 2017 |
| Risk-adapted management of differentiated thyroid cancer assessed by a sensitive measurement of basal serum thyroglobulin P Malandrino, A Latina, S Marescalco, A Spadaro, C Regalbuto, RA Fulco, ... The Journal of Clinical Endocrinology & Metabolism 96 (6), 1703-1709, 2011 | 146 | 2011 |
| Papillary thyroid microcarcinomas: a comparative study of the characteristics and risk factors at presentation in two cancer registries P Malandrino, G Pellegriti, M Attard, MA Violi, C Giordano, L Sciacca, ... The Journal of Clinical Endocrinology & Metabolism 98 (4), 1427-1434, 2013 | 119 | 2013 |
| Increased thyroid cancer incidence in a basaltic volcanic area is associated with non-anthropogenic pollution and biocontamination P Malandrino, M Russo, A Ronchi, C Minoia, D Cataldo, C Regalbuto, ... Endocrine 53, 471-479, 2016 | 94 | 2016 |
| A diffuse sclerosing variant of papillary thyroid carcinoma: clinical and pathologic features and outcomes of 34 consecutive cases C Regalbuto, P Malandrino, A Tumminia, R Le Moli, R Vigneri, V Pezzino Thyroid 21 (4), 383-389, 2011 | 86 | 2011 |
| The influence of the environment on the development of thyroid tumors: a new appraisal MA Marcello, P Malandrino, JFM Almeida, MB Martins, LL Cunha, ... Endocrine-related cancer 21 (5), T235-T254, 2014 | 79 | 2014 |
| Prognostic markers of survival after combined mitotane-and platinum-based chemotherapy in metastatic adrenocortical carcinoma P Malandrino, A Al Ghuzlan, M Castaing, J Young, B Caillou, JP Travagli, ... Endocrine-Related Cancer 17 (3), 797, 2010 | 68 | 2010 |
| Thyroid cancer in thyroglossal duct cysts requires a specific approach due to its unpredictable extension G Pellegriti, G Lumera, P Malandrino, A Latina, R Masucci, C Scollo, ... The Journal of Clinical Endocrinology & Metabolism 98 (2), 458-465, 2013 | 67 | 2013 |
| Descriptive epidemiology of human thyroid cancer: experience from a regional registry and the “volcanic factor” P Malandrino, C Scollo, I Marturano, M Russo, M Tavarelli, M Attard, ... Frontiers in Endocrinology 4, 65, 2013 | 57 | 2013 |
| Fathoming the link between anthropogenic chemical contamination and thyroid cancer V Marotta, P Malandrino, M Russo, I Panariello, F Ionna, MG Chiofalo, ... Critical Reviews in Oncology/Hematology 150, 102950, 2020 | 50 | 2020 |
| Outcome of the diffuse sclerosing variant of papillary thyroid cancer: a meta-analysis P Malandrino, M Russo, C Regalbuto, G Pellegriti, M Moleti, A Caff, ... Thyroid 26 (9), 1285-1292, 2016 | 48 | 2016 |
| Prognostic factors for adrenocortical carcinoma outcomes C Scollo, M Russo, MA Trovato, D Sambataro, D Giuffrida, M Manusia, ... Frontiers in Endocrinology 7, 99, 2016 | 47 | 2016 |
| The BRAFV600E mutation influences the short-and medium-term outcomes of classic papillary thyroid cancer, but is not an independent predictor of unfavorable outcome M Russo, P Malandrino, ML Nicolosi, M Manusia, I Marturano, MA Trovato, ... Thyroid 24 (8), 1267-1274, 2014 | 47 | 2014 |
| Update on thyroid cancer treatment C Regalbuto, F Frasca, G Pellegriti, P Malandrino, I Marturano, I Di Carlo, ... Future Oncology 8 (10), 1331-1348, 2012 | 46 | 2012 |
| Activation of the IGF axis in thyroid cancer: implications for tumorigenesis and treatment L Manzella, M Massimino, S Stella, E Tirrò, MS Pennisi, F Martorana, ... International journal of molecular sciences 20 (13), 3258, 2019 | 43 | 2019 |
| Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective G Muscogiuri, B Altieri, M Albertelli, A Dotto, R Modica, L Barrea, ... Endocrine 69, 441-450, 2020 | 40 | 2020 |
| Predictive factors of response to mTOR inhibitors in neuroendocrine tumours MC Zatelli, G Fanciulli, P Malandrino, V Ramundo, A Faggiano, A Colao Endocrine-related cancer 23 (3), R173-R183, 2016 | 38 | 2016 |
| Familial non-medullary thyroid cancer represents an independent risk factor for increased cancer aggressiveness: a retrospective analysis of 74 families M Tavarelli, M Russo, R Terranova, C Scollo, A Spadaro, G Sapuppo, ... Frontiers in endocrinology 6, 117, 2015 | 38 | 2015 |
Gabriella Pellegriti, MD, PhDResearcher of Medical Oncology, Dept. of Clinical and Experimental Medicine, University of CataniaEmail verificata su unict.it
